Layer-by-Layer Polymeric Films: A Novel Approach to Buccal GLP-1 Delivery
Eleftheria PantazoglouiD, Floriane Bahuon, Amalie Kjær AndreseniD, Matteo TollemetoiD, Zhongyang ZhangiD, Ioannis Tzitzigiannis, Nazanin Zanjanizadeh Ezazi, Margarida M. A. SacramentoiD, João Filipe ManoiD, Gavrielle Rebecca UntrachtiD, Peter E. Andersen, Marco van de WeertiD, Ragna BerthelseniD, Stephen Timothy BuckleyiD, Leticia Hosta‐RigauiD, E. N. Jacobsen, Line Hagner NielseniD
Abstract
Buccal delivery offers a promising alternative to oral drug administration by enabling direct systemic absorption and avoiding first-pass metabolism. Multilayer polymeric films represent a promising strategy for the sequential delivery of drug and absorption enhancer in the oral cavity. Here, dual- and triple-layer films were fabricated via slot-die coating, incorporating a GLP-1 receptor agonist (GLP-1-RA) and the penetration enhancer sodium glycodeoxycholate (GDC). These were co-loaded in dual-layer films or compartmentalized in triple-layer films. Scanning electron microscopy and optical coherence tomography confirmed well-defined, distinct layers with thicknesses suitable for buccal administration (339 {+/-} 10.24 {micro}m and 487 {+/-} 36.5 {micro}m for dual- and triple-layer films, respectively). Both designs exhibited good mucoadhesion and mucosal compatibility, and preserved the secondary structure of GLP-1-RA. In vitro release studies showed rapid diffusion of GDC and GLP-1-RA from dual-layer films, whereas triple-layer films enabled sustained, sequential release of GDC and GLP-1-RA. Ex vivo porcine buccal mucosa studies showed higher GLP-1-RA and GDC flux from triple-layer films compared to dual-layer films. The films also did not compromise epithelial integrity, in contrast to the direct application of GLP-1-RA and GDC, which caused significant epithelial disruption. These results demonstrate that multilayer film architecture and spatial layering can be harnessed to control release kinetics, maximize peptide penetration, and minimize tissue stress, offering a versatile platform for safe and effective peptide delivery. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=93 SRC="FIGDIR/small/700335v1_ufig1.gif" ALT="Figure 1"> View larger version (25K): org.highwire.dtl.DTLVardef@76858borg.highwire.dtl.DTLVardef@1397e74org.highwire.dtl.DTLVardef@19d1841org.highwire.dtl.DTLVardef@a369c5_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Sustained release and pharmacologic effects of human glucagon-like peptide-1 and liraglutide from polymeric microparticles.
L. P. Icart, F. G. Souza, L. M. Lima·bioRxiv·Feb 9, 2018
- Gut delivery of pentameric GLP-1 using genetically engineered Bacillus subtilis
Ningyuan Ye, Francesco Di Pierro, … Jiahe Li·ACS Synthetic BiologyPeer-reviewed·Oct 27, 2026
- Nanoparticle-in-Microparticle Oral Delivery System Based on Drug-Loaded Polymeric Micelles
Hen Moshe Halamish, Roni Sverdlov Arzi, Alejandro Sosnik·Chemical CommunicationsPeer-reviewed·Jan 1, 2026
- Structural basis of peptidomimetic agonism revealed by small molecule GLP-1R agonists Boc5 and WB4-24
Zhaotong Cong, Qingtong Zhou, … Ming‐Wei Wang·Proceedings of the National Academy of SciencesPeer-reviewed·May 13, 2022
- Oral delivery of the amylin receptor agonist pramlintide
C. Sinezia, T. Sisnande, … L. M. T. Lima·bioRxiv·Nov 9, 2023
- Sustained Delivery of GLP-1 Receptor Agonists from Injectable Biomimetic Hydrogels Improves Treatment of Diabetes
A. I. d'Aquino, C. L. Maikawa, … E. A. Appel·bioRxiv·Jan 28, 2023